Why British Urology Should Support RADICALS despite Initial Slow Recruitment

Thompson IM Tangen CM Paradelo J Lucia MS Miller G Troyer D Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. The Journal of Urology 2009;181(March (3)):956–62.

Bolla M van Poppel H Collette L van Cangh P Vekemans K Da Pozzo L Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005;366(August (9485)):572–8.

Wiegel T Bottke D Steiner U Siegmann A Golz R Storkel S Phase III postoperative adjuvant radiotherapyafter radical prostatectomy compared with radical prostatecomy alone in pT3 prostate cancer with postoperative undetectable prostate specific antigen: ARO 96-02/AUO AP 09/95. Journal of Clinical Oncology 2009;(June (18)):2924–30.

Collette L van Poppel H Bolla M van Cangh P Vekemans K Da Pozzo European Organisation for Research and Treatment of Cancer (EORTC) Radiotherapy and Genitourinary Groups. Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911). European Journal of Cancer 2005;41(November (17)):2662–72.